Pharmacological Properties of Salmeterol

University of Copenhagen

Status and phase: Completed; Phase 4

Conditions: Pharmacokinetics in Healthy Young Men

Treatments: Drug: Salmeterol

Study type: Interventional

Funder types: Other

Identifiers

NCT02558088

WADA2013sal

Details and patient eligibility

About

The objective of the study is to help establish a urinary threshold for salmeterol on the World Anti-doping Agency prohibited list, to avoid supratherapeutic of this substance in competitive sports.

Hence, there is no hypothesis as such.

Enrollment: 11 patients

Sex: Male

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male
• 18-45 years
• Healthy

Exclusion criteria

• Chronic disease
• Smoking
• Habitual use of medicine
• Allergy towards salmeterol
• Unable to exercise on a bike ergometer

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

11 participants in 1 patient group

salmeterol

Experimental group

Treatment:

Drug: Salmeterol